Delays in Continuous Glucose Monitoring Device Initiation: A Single Center Experience and a Call to Change

7. Diabetes Technology: Standards of Medical Care in Diabetes—2022

(2021)   DIABETES CARE

Advanced Diabetes Technology Remains Underutilized in Underserved Populations: Early Hybrid Closed-Loop System Experience at an Academic Safety Net Hospital

(2021) Zhihui Ju et al.   Diabetes Technology & Therapeutics

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

(2019) Nicole C. Foster et al.   Diabetes Technology & Therapeutics

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

The CGM grey market: a reflection of global access inequity

(2019) Oana Onisie et al.   Lancet Diabetes & Endocrinology

Current Eligibility Requirements for Continuous Glucose Monitoring Coverage Are Harmful, Costly, and Unjustified

(2019) John E. Anderson et al.   Diabetes Technology & Therapeutics

Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets

(2016) Molly L. Tanenbaum et al.   DIABETES CARE

Massachusetts Health Reform At Ten Years: Great Progress, But Coverage Gaps Remain

(2016) Sharon K. Long et al.   HEALTH AFFAIRS